Thermo Fisher Scientific establishes U.S. Precision Medicine Science Center

Thermo Fisher Scientific, a biotechnology product developer, opened the U.S. Precision Medicine Science Center in Cambridge, Mass., which aims to provide access to technologies and expertise that furthers precision medicine.

The center will offer collaborators access to advanced technologies spanning genomic, proteomic and metabolomic analysis. It will also offer access to its team of in-house scientists who can help collaborators progress from biomarker discovery to assay development.

"Precision medicine needs to be based on high-quality data, and proteomics is central to that," said Jennifer Van Eyk, PhD, of Cedars-Sinai Medical Center in Los Angeles, a center collaborator. "Our work with the team at the PMSC is helping us accelerate the important journey from discovery to patient care."

Thermo Fisher Scientific also opened Precision Medicine Science Center in Guangzhou, China in 2017.

More articles on precision medicine:
Cleveland Clinic to open 21k-square-foot biobank
Provider Data Action Alliance releases road map for trustworthy provider data
NIH seeks genome centers to sequence data from 200k 'All of Us' participants per year: 4 things to know

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months